Role of inflammatory markers in the evaluation of indeterminate pulmonary nodules:a review  

作　　者：Qiao-Li Wang Xiao-Qin Liu Ting Wang 

机构地区：[1]Department of Health Screening Center,Deyang Peoples'Hospital,Deyang 618000,China.

出　　处：《Clinical Research Communications》2024年第3期48-52,共5页临床研究通讯

基　　金：the technology research and development project of Deyang Science and Technology Bureau,grant number[2022SCZ137].

摘　　要：The global mortality rate of lung cancer surpasses that of any other type of cancer,establishing it as the foremost cause of cancer-related deaths worldwide.The objectives of lung nodule assessment are to expedite the diagnosis and treatment of patients with malignant nodules while minimizing unnecessary diagnostic procedures for those with benign nodules.The systemic inflammatory response is closely linked to tumorigenesis.Serum levels of inflammatory markers and their derived parameters markers including neutrophil-to-lymphocyte ratio(NLR),lymphocyte-to-monocyte ratio(LMR),monocyte-to-albumin ratio(MAR),platelet-to-lymphocyte ratio(PLR)and systemic immune‐inflammation index(SII),closely associated with lung cancer.The objective of this article is to comprehensively evaluate the differentiation between benign and malignant pulmonary nodules in terms of inflammatory response indicators,aim at provide practical recommendations for the clinical diagnosis,treatment,and management of pulmonary nodules.

关 键 词：lung nodules inflammatory makers lung cancer 

分 类 号：R73[医药卫生—肿瘤]